Literature DB >> 26895219

Recurrent IgA Nephropathy After Kidney Transplantation.

Melanie L Wyld1, Steven J Chadban.   

Abstract

Large numbers of patients with end-stage kidney disease caused by IgA nephropathy are transplanted every year, and each of these patients faces the risk of recurrence in their kidney graft. We review the epidemiology, diagnosis, and outcomes of recurrent IgA nephropathy. Mechanistic insights, therapeutic options, and knowledge gaps are reviewed, and we discuss future options to better understand and manage this disorder.

Entities:  

Mesh:

Year:  2016        PMID: 26895219     DOI: 10.1097/TP.0000000000001093

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  Stop TRPC5 in Kidney Disease: A Game Changer for Renal Allograft Protection?

Authors:  Xuexiang Wang; Jochen Reiser
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

Review 2.  Precision Transplant Medicine: Biomarkers to the Rescue.

Authors:  Maarten Naesens; Dany Anglicheau
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

3.  Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.

Authors:  Francois Berthoux; Hitoshi Suzuki; Hesham Mohey; Nicolas Maillard; Christophe Mariat; Jan Novak; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 10.121

4.  Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.

Authors:  Rupali S Avasare; Paul E Rosenstiel; Ziad S Zaky; Demetra S Tsapepas; Gerald B Appel; Glen S Markowitz; Andrew S Bomback; Pietro A Canetta
Journal:  Am J Nephrol       Date:  2017-01-06       Impact factor: 3.754

5.  Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.

Authors:  Maria Messina; Maria Cristina di Vico; Claudia Ariaudo; Gianna Mazzucco; Fabrizio Fop; Giuseppe Paolo Segoloni; Luigi Biancone
Journal:  J Nephrol       Date:  2016-05-23       Impact factor: 3.902

6.  Clinical Features, Treatment and Prognostic Factors of Post-Transplant Immunoglobulin A Nephropathy.

Authors:  Diogo Buarque Cordeiro Cabral; Tainá Veras de Sandes-Freitas; José Osmar Medina-Pestana; Gianna Mastroianni-Kirsztajn
Journal:  Ann Transplant       Date:  2018-03-09       Impact factor: 1.530

Review 7.  Recurrent and de novo Glomerulonephritis After Kidney Transplantation.

Authors:  Wai H Lim; Meena Shingde; Germaine Wong
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

8.  Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study.

Authors:  Sehoon Park; Chung Hee Baek; Heounjeong Go; Young Hoon Kim; Sang-Il Min; Jongwon Ha; Yong Chul Kim; Jung Pyo Lee; Yon Su Kim; Kyung Chul Moon; Su-Kil Park; Hajeong Lee
Journal:  BMC Nephrol       Date:  2019-09-11       Impact factor: 2.388

9.  Recurrence of IgA Nephropathy after Kidney Transplantation in Adults.

Authors:  Audrey Uffing; Maria José Pérez-Saéz; Thomas Jouve; Mathilde Bugnazet; Paolo Malvezzi; Saif A Muhsin; Marie-Camille Lafargue; Roman Reindl-Schwaighofer; Alina Morlock; Rainer Oberbauer; Anna Buxeda; Carla Burballa; Julio Pascual; Seraina von Moos; Harald Seeger; Gaetano La Manna; Giorgia Comai; Claudia Bini; Luis Sanchez Russo; Samira Farouk; Pitchaphon Nissaisorakarn; Het Patel; Nikhil Agrawal; Gianna Mastroianni-Kirsztajn; Juliana Mansur; Hélio Tedesco-Silva; Carlucci Gualberto Ventura; Fabiana Agena; Elias David-Neto; Enver Akalin; Omar Alani; Marilda Mazzali; Roberto Ceratti Manfro; Andrea Carla Bauer; Aileen X Wang; Xingxing S Cheng; Jesse D Schold; Stefan P Berger; Paolo Cravedi; Leonardo V Riella
Journal:  Clin J Am Soc Nephrol       Date:  2021-08       Impact factor: 10.614

10.  Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.

Authors:  Anne-Sophie Garnier; Agnès Duveau; Julien Demiselle; Anne Croué; Jean-François Subra; Johnny Sayegh; Jean-François Augusto
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.